Type-IV hypersensitivity to topical estradiol in a patient tolerant to it orally.
Boehncke
W H
WH
Department of Dermatology, University of Ulm, Germany.
Gall
H
H
D000279:Administration, Cutaneous; D000284:Administration, Oral; D003875:Drug Eruptions / Q000209:etiology*; D004890:Erythema / Q000139:chemically induced; D004958:Estradiol / Q000008:administration & dosage / Q000009:adverse effects*; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced*; D008875:Middle Aged; D011537:Pruritus / Q000139:chemically induced; D014581:Urticaria / Q000139:chemically induced
D004966:Estrogens, Conjugated (USP); D004958:Estradiol